- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Kira keeps series B-plus funding
The Sinopharm and WuXi AppTec-backed, complement system-focused drug developer has hauled in $53.3m of new funding after emerging from stealth late last year.
Jan 14, 2021Tencent lays down series B cash for Raysight
The cardiovascular treatment device developer raised about $46m in a round led by Tencent and has now secured roughly $60m altogether.
Jan 14, 2021Dable to deploy $12m from series C
Kakao Ventures helped content discovery platform Dable achieve a $90m valuation in a series C round taking its total funding past $20m.
Jan 13, 2021Ivy Dad graduates to $30m series B
Fivestar Holdings took part in a series B round for the early education platform developer through investment vehicle Focustar Capital.
Jan 13, 2021CareerGig recruits Moonlighting
McClatchy, Gannett and Tonc have exited the gig-economy recruitment platform in an acquisition by peer CareerGig.
Jan 13, 2021Cardea Bio amplifies series A funding
The transistor technology developer has disclosed $21.8m in series A funding from investors including Agilent Technologies across three tranches.
Jan 13, 2021Neat Capital houses series B funds
American Family’s venture capital unit has contributed to a $22.5m round that will support the digital mortgage lender's US expansion.
Jan 13, 2021Weber cooks up June acquisition
Weber has bought the smart oven producer, one of its portfolio companies, in a deal that allows Amazon Alexa Fund to exit.
Jan 13, 2021Lexeo stacks up $85m
Weill Cornell Medicine‘s monogenic diseases therapy developer Lexeo Therapeutics has made its public debut with $85m in series A financing.
Jan 13, 2021Tessera impresses with $230m series B
Genomic drug developer Tessera Therapeutics raised $230m in a round co-led by SoftBank Vision Fund 2 as it works on its gene writing technology.
Jan 13, 2021GIC gees up View with $200m
Corning and SoftBank-backed dynamic glass producer View's previously announced reverse merger will be boosted by $200m from Singapore's sovereign wealth fund.
Jan 13, 2021Cockroach files away $160m in funding
GV helped longtime portfolio company and database platform developer Cockroach Labs take its total funding to $355m at a $2bn valuation.
Jan 13, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


